Get the content you want anytime you want.
IDWeek 2019

Select coverage from IDWeek 2019 is included below:

Next Steps for HCV Vaccine Development
Andrea L. Cox, MD, PhD, comments on the future of HCV vaccine development efforts in light of the 2019 trial which did not prevent chronic infection.
Lessons From An HCV Vaccine Trial
Andrea L. Cox, MD, PhD, discusses the implications of discovering that an experimental vaccine was not effective at preventing chronic hepatitis C virus.
What is Antiretroviral Stewardship?
Daniel B. Chastain, PharmD, BCIDP, AAHIVP, clinical assistant professor at the University of Georgia College of Pharmacy, explains antiretroviral stewardship.
Are Transgender Women Underrepresented in Sexual Health Research?
Max Brito, MD, MPH, remarks on the underrepresentation of transgender women in HIV and other sexual health research.
Cefiderocol vs High-Dose Meropenem for the Treatment of Patients With Nosocomial Pneumonia
Ryan K. Shields, PharmD, MS, reacts to research presented at IDWeek 2019 on cefiderocol versus high-dose meropenem for patients with nosocomial pneumonia.
Shikha Garg, MD, MPH: Influenza Vaccination Associated With Reduced Odds of Severe Outcomes
A study by Shikha Garg, MD, MPH, and her team with the US Centers for Disease Control and Prevention boosts the evidence base for the benefit of influenza vaccination.
Community-Based HIV Care Models in Chicago
Max Brito, MD, MPH, discusses his presentation from IDWeek 2019 which compared HIV treatment in a community-based model versus a hospital-based model in Chicago.
Overarching Themes of IDWeek 2019
Erin McCreary, PharmD, BCPS, BCIDP, shares her takeaways from IDWeek 2019.